2-aryl benzimidazole conjugate induced apoptosis in human breast cancer MCF-7 cells through caspase independent pathway

Tao Z, Shi A, Lu C, Song T, Zhang Z, Zhao J (2015) Breast cancer: epidemiology and etiology. Cell Biochem Biophys 72(2):333–338. doi:10.1007/s12013-014-0459-6 Liu Z, Ding Y, Ye N, Wild C, Chen H, Zhou J (2016) Direct activation of Bax protein for cancer therapy. Med Res Rev 36(2):313–341. doi:10.1002/med.21379 Xin M, Li R, Xie M, Park D, Owonikoko TK, Sica GL, Corsino PE, Zhou J, Ding C, White MA, Magis AT, Ramalingam SS, Curran WJ, Khuri FR, Deng X (2014) Small-molecule Bax agonists for cancer therapy. Nat Commun 5:4935. doi:10.1038/ncomms5935 Liu Z, Wild C, Ding Y, Ye N, Chen H, Wold EA, Zhou J (2016) BH4 domain of Bcl-2 as a novel target for cancer therapy. Drug Discov Today 21(6):989–996. doi:10.1016/j.drudis.2015.11.008 Han B, Park D, Li R, Xie M, Owonikoko TK, Zhang G, Sica GL, Ding C, Zhou J, Magis AT, Chen ZG, Shin DM, Ramalingam SS, Khuri FR, Curran WJ, Deng X (2015) Small-molecule Bcl2 BH4 antagonist for lung cancer therapy. Cancer Cell 27(6):852–863. doi:10.1016/j.ccell.2015.04.010 Toshiya K, Testuya T, Akira H, Takuji T (2012) Cancer chemoprevention through the induction of apoptosis by natural compounds. J Biophys Chem 3:156–173. doi:10.4236/jbpc.2012.32018 Chou CC, Yang JS, Lu HF, Ip SW, Lo C, Wu CC, Lin JP, Tang NY, Chung JG, Chou MJ, Teng YH, Chen DR (2010) Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells. Arch Pharm Res 33(8):1181–1191. doi:10.1007/s12272-010-0808-y Kemnitzer W, Kuemmerle J, Jiang S, Zhang HZ, Sirisoma N, Kasibhatla S, Crogan-Grundy C, Tseng B, Drewe J, Cai SX (2008) Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. Part 1: structure–activity relationships of the 1- and 3-positions. Bioorg Med Chem Lett 18(23):6259–6264. doi:10.1016/j.bmcl.2008.09.110 Kemnitzer W, Sirisoma N, Nguyen B, Jiang S, Kasibhatla S, Crogan-Grundy C, Tseng B, Drewe J, Cai SX (2009) Discovery of N-aryl-9-oxo-9H-fluorene-1-carboxamides as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure–activity relationships of the carboxamide group. Bioorg Med Chem Lett 19(11):3045–3049. doi:10.1016/j.bmcl.2009.04.009 Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70. 10.1016/S0092-8674(00)81683-9 Nitiss JL (2009) DNA topoisomerase II and its growing repertoire of biological functions. Nat Rev Cancer 9(5):327–337. doi:10.1038/nrc2608 Vos SM, Tretter EM, Schmidt BH, Berger JM (2011) All tangled up: how cells direct, manage and exploit topoisomerase function. Nat Rev Mol Cell Biol 12(12):827–841. doi:10.1038/nrm3228 Bailly C (2012) Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy. Chem Rev 112(7):3611–3640. doi:10.1021/cr200325f Pommier Y (2009) DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition. Chem Rev 109(7):2894–2902. doi:10.1021/cr900097c Pommier Y (2013) Drugging topoisomerases: lessons and challenges. ACS Chem Biol 8(1):82–95. doi:10.1021/cb300648v Nitiss JL (2009) Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 9(5):338–350. doi:10.1038/nrc2607 Nitiss JL (1998) Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochim Biophys Acta 1400(1–3):63–81. doi:10.1016/S0167-4781(98)00128-6 Fortune JM, Osheroff N (2000) Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. Prog Nucleic Acid Res Mol Biol 64:221–253. doi:10.1016/S0079-6603(00)64006-0 Wilstermann AM, Osheroff N (2003) Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes. Curr Top Med Chem 3(3):321–338. doi:10.2174/1568026033452519 Bromberg KD, Burgin AB, Osheroff N (2003) A two-drug model for etoposide action against human topoisomerase II alpha. J Biol Chem 278:7406–7412. doi:10.1074/jbc.M212056200 Wang JC (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 3(6):430–440. doi:10.1038/nrm831 Gao C, Li B, Zhang B, Sun Q, Li L, Li X, Chen C, Tan C, Liu H, Jiang Y (2015) Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents. Bioorg Med Chem 23(8):1800–1807. doi:10.1016/j.bmc.2015.02.036 Singla P, Luxami V, Paul K (2015) Triazine-benzimidazole hybrids: anticancer activity, DNA interaction and dihydrofolate reductase inhibitors. Bioorg Med Chem 23(8):1691–1700. doi:10.1016/j.bmc.2015.03.012 Paul K, Sharma A, Luxami V (2014) Synthesis and in vitro antitumor evaluation of primary amine substituted quinazoline linked benzimidazole. Bioorg Med Chem Lett 24(2):624–629. doi:10.1016/j.bmcl.2013.12.005 Hu Z, Ou L, Li S et al (2014) Synthesis and biological evaluation of 1-cyano-2-amino-benzimidazole derivatives as a novel class of antitumor agents. Med Chem Res 23, 3029–3038. doi:10.1007/s00044-013-0888-6 Kamal A, Srinivasulu V, Sathish M, Tangella Y, Nayak VL, Narasimha Rao MP, Shankaraiah N, Nagesh N (2014) Palladium-catalyzed aryl C–H activation and tandem ortho-hydroxylation/alkoxylation of 2-aryl benzimidazoles: cytotoxicity and DNA-binding studies. Asian J Org Chem 3:68–76. doi:10.1002/ajoc.201300214 Szumilak M, Szulawska-Mroczek A, Koprowska K, Stasiak M, Lewgowd W, Stanczak A, Czyz M (2010) Synthesis and in vitro biological evaluation of new polyamine conjugates as potential anticancer drugs. Eur J Med Chem 45(12):5744–5751. doi:10.1016/j.ejmech.2010.09.032 Shankar R, Chakravarti B, Singh US, Ansari MI, Deshpande S, Dwivedi SK, Bid HK, Konwar R, Kharkwal G, Chandra V, Dwivedi A, Hajela K (2009) Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents. Bioorg Med Chem 17(11):3847–3856. doi:10.1016/j.bmc.2009.04.032 Chakravarti B, Maurya R, Siddiqui JA, Bid HK, Rajendran SM, Yadav PP, Konwar R (2012) In vitro anti-breast cancer activity of ethanolic extract of Wrightia tomentosa: role of pro-apoptotic effects of oleanolic acid and urosolic acid. J Ethnopharmacol 142:72–79. doi:10.1016/j.jep.2012.04.015 Ding G, Liu F, Yang T, Jiang Y, Fu H, Zhao Y (2006) A novel kind of nitrogen heterocycle compound induces apoptosis of human chronic myelogenous leukemia K562 cells. Bioorg Med Chem 14(11):3766–3774. doi:10.1016/j.bmc.2006.01.050 Keerthy HK, Garg M, Mohan CD, Madan V, Kanojia D, Shobith R, Nanjundaswamy S, Mason DJ, Bender A, Basappa, Rangappa KS, Koeffler HP (2014) Synthesis and characterization of novel 2-amino-chromene-nitriles that target Bcl-2 in acute myeloid leukemia cell lines. PLoS One 9:e107118. doi:10.1371/journal.pone.0107118 Hayano T, Garg M, Yin D, Sudo M, Kawamata N, Shi S, Chien W, Ding LW, Leong G, Mori S, Xie D, Tan P, Phillip KH (2013) SOX7 is down-regulated in lung cancer. J Exp Clin Cancer Res 32:17. doi:10.1186/1756-9966-32-17 Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME, Debatin KM (1998) Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem 273:33942–33948. doi:10.1074/jbc.273.51.33942 Sánchez-Alcázar JA, Schneider E, Martínez MA, Carmona P, Hernández-Muñoz I, Siles E, De La Torre P, Ruiz-Cabello J, García I, Solis-Herruzo JA (2000) Tumor necrosis factor-alpha increases the steady-state reduction of cytochrome b of the mitochondrialrespiratory chain in metabolically inhibited L929 cells. J Biol Chem 275:13353–13361. doi:10.1074/jbc.275.18.13353 Bossy-Wetzel E, Newmeyer DD, Green DR (1998) Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 17:37–49. doi:10.1093/emboj/17.1.37 Shafi G, Munshi A, Hasan Tarique N, Alshatwi Ali A, Jyothy A, Lei David KY (2009) Induction of apoptosis in HeLa cells by chloroform fraction of seed extracts of Nigella sativa. Cancer Cell Int 9:1–8. doi:10.1186/1475-2867-9-29 Botta M, Armaroli S, Castagnolo D, Fontana G, Pera P, Bombardelli E (2007) Synthesis and biological evaluation of new taxoids derived from 2-deacetoxytaxinine J. Bioorg Med Chem Lett 17(6):1579–1583. doi:10.1016/j.bmcl.2006.12.101 Kulkarni P, Patnaik Rao KSK, Ramakrishna S (2015) Piperlonguimine indeces cell death via ros generation, atp depletion, glutathione depletion and dissipation of mitochondrial membrane potiential in Human breast cancer cell line. Int J Pharm Bio Sci 6(2):293–302 Wei H, Ruthenburg AJ, Bechis SK, Verdine GL (2005) Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase. J Biol Chem 280(44):37041–37047. doi:10.1074/jbc.M506520200 Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785–2791. doi:10.1002/jcc.21256 Delano WL (2002) The PyMOL Molecular Graphics System. DeLano Scientific, San Carlos Chan KT, Meng FY, Li Q, Ho CY, Lam TS, To Y, Lee WH, Li M, Chu KH, Toh M (2010) Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration. Cancer Lett 294(1):118–124. doi:10.1016/j.canlet.2010.01.029 Shen JK, Du HP, Yang M, Wang YG, Jin J (2009) Casticin induces leukemic cell death through apoptosis and mitotic catastrophe. Ann Hematol 88(8):743–752.doi:10.1007/s00277-008-0677-3 Woessner RD, Mattern MR, Mirabelli CK, Johnson RK, Drake FH (1991) Proliferation and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ 2:209–214 Wells NJ, Hickson ID (1995) Human topoisomerase II alpha is phosphorylated in a cell cycle phase-dependent manner by a proline-directed kinase. Eur J Biochem 231:491–497. doi:10.1111/j.1432-1033.1995.0491e.x Isaacs RJ, Davies SL, Sandri MI, Redwood C, Wells NJ, Hickson ID (1998) Physiological regulation of eukaryotic topoisomerase II. Biochim Biophys Acta 1(98):00131–00136. doi:10.1016/S0167478 Bromberg KD, Burgin AB, Osheroff N (2003) A two-drug model for etoposide action against human topoisomerase IIalpha. J Biol Chem 278:7406–7412. doi:10.1074/jbc.M212056200 Nitiss JL, Beck WT (1996) Antitopoisomerase drug action and resistance. Eur J Cancer 32A(6):958–966. doi:10.1016/0959-8049(96)00056-1 Pommier Y, Leo E, Zhang H, Marchand C (2010) DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 17(5):421–433. doi:10.1016/j.chembiol.2010.04.012 Gonda K, Tsuchiya H, Sakabe T, Akechi Y, Ikeda R, Nishio R, Terabayashi K, Ishii K, Matsumi Y, Ashla AA, Okamoto H, Takubo K, Matsuoka S, Watanabe Y, Hoshikawa Y, Kurimasa A, Shiota G (2008) Synthetic retinoid CD437 induces mitochondriamediated apoptosis in hepatocellular carcinoma cells. Biochem Biophys Res Commun 370:629–633. doi:10.1016/j.bbrc.2008.04.008 Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C (1993) A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 197(1):40–45. doi:10.1006/bbrc.1993.2438 Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A (1997) JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess ∆Ψ changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411:77–82. doi:10.1016/S0014-5793(97)00669-8 Sánchez Y, Simón GP, Calviño E, de Blas E, Aller P (2010) Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines. J Pharmacol Exp Ther 335(1):114–123. doi:10.1124/jpet.110.168344 Liu K, Zhang D, Chojnacki J, Du Y, Fu H, Grant S, Zhang S (2013) Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma. Org Biomol Chem 11:4757–4763. doi:10.1039/C3OB40595H Konstantinov SM, Berger MR (1999) Human urinary bladder carcinoma cell lines respond to treatment with alkylphosphocholines. Cancer Lett 144(2):153–160. doi:10.1016/S0304-3835(99)00219-0 Bunz F (2001) Cell death and cancer therapy. Curr Opin Pharmacol 1(4):337–341. doi:10.1016/S1471-4892(01)00059-5 Tor YS, Yazan LS, Foo JB, Wibowo A, Ismail N, Cheah YK, Abdullah R, Ismail M, Ismail IS, Yeap SK (2015) Induction of apoptosis in MCF-7 cells via oxidative stress generation, mitochondria-dependent and caspase independent pathway by ethyl acetate extract of Dillenia suffruticosa and its chemical profile. PLoS One 10:e0127441. doi:10.1371/journal.pone.0127441 Hu CC, Tang CH, Wang JJ (2001) Caspase activation in response to cytotoxic rana catesbeiana ribonuclease in MCF-7 cells. FEBS Lett 503:65–68. doi:10.1016/S0014-5793(01)02691-6 Xuejun J, Xiaodong W (2004) Cytochrome c-mediated apoptosis. Ann Rev Biochem 73:87–106. doi:10.1146/annurev.biochem.73.011303.073706 Costantini P, Bruey JM, Castedo M, Métivier D, Loeffler M, Susin SA, Ravagnan L, Zamzami N, Garrido C, Kroemer G (2002) Pre-processed caspase-9 contained in mitochondria participates in apoptosis. Cell Death Differ 9:82–88. doi:10.1038/sj/cdd/4400932 Otera H, Ohsakaya S, Nagaura Z, Ishihara N, Mihara K (2005) Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space. EMBO J 24(7):1375–1386. doi:10.1038/sj.emboj.7600614 Qiao L, Wong BC (2009) Targeting apoptosis as an approach for gastrointestinal cancer therapy. Drug Resist Updat 12(3):55–64. doi:10.1016/j.drup.2009.02.002 Bernardi P, Vassanelli S, Veronese P, Colonna R, Szabó I, Zoratti M (1992) Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J Biol Chem 267(5):2934–2939 Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6(5):513–519. doi:10.1038/74994 Parreño M, Casanova I, Céspedes MV, Vaqué JP, Pavón MA, Leon J, Mangues R (2008) Bobel-24 and derivatives induce caspase-independent death in pancreatic cancer regardless of apoptotic resistance. Cancer Res 68(15):6313–6323. doi:10.1158/0008-5472.CAN-08-1054 Shrivastava A, Tiwari M, Sinha RA, Kumar A, Balapure AK, Bajpai VK, Sharma R, Mitra K, Tandon A, Godbole MM (2006) Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. J Biol Chem 281(28):19762–19771. doi:10.1074/jbc.M60074